UCLA has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative ...
A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even after first-line treatment fails.
New research from UNC Charlotte's Center for Computational Intelligence to Predict Health and Environmental Risks (CIPHER) ...
In an "Industry Watch" research paper in the journal Tobacco Control, two scientists at the University of California, ...
A new editorial paper was published in Oncotarget's Volume 15 on July 2, 2024, entitled, "DDX41 and its unique contribution ...
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on ...
A new research perspective was published in (Volume 11) on May 23, 2024, entitled, "Targeting inflammatory factors for chemoprevention and cancer interception to tackle malignant mesothelioma." ...
New recommendations for screening and treatment are based on the results of a major national study led at UCSF.
Through precision medicine, the University of Virginia is working toward a world in which no more pink ribbons are necessary. To that end, Susan G. Komen announced support this summer for the UVA ...
The international study, co-authored by the Department of Sociology and the Leverhulme Centre for Demographic Science's Dr ...
Marshall University was awarded a $3.3 million grant (#R01DA057931) from the National Institute on Drug Abuse (NIDA) to examine the genetic mechanisms that underlie fentanyl addiction.